MPO and kidney disorder: This was in line with previously reported beneficial effects of anti-ApoA2, such as effective recovery from renal disorders and decreased levels of MPO-ANCA and inflammatory cytokines in SCG/Kj mice models of MPO-ANCA-associated vasculitis (MAAV) [12].